1. Effect of upper body venoarterial ECMO on systemic hemodynamics and oxygenation: A computational study.
- Author
-
Moradi H, Seethala RR, Edelman ER, Keller SP, and Nezami FR
- Subjects
- Humans, Computer Simulation, Respiratory Insufficiency therapy, Respiratory Insufficiency physiopathology, Extracorporeal Membrane Oxygenation methods, Hemodynamics physiology, Oxygen metabolism, Models, Cardiovascular
- Abstract
Background: This study seeks to quantify the effects of upper body veno-arterial extracorporeal membrane oxygenation (VA ECMO) on the anatomical distribution of oxygen delivery in the setting of hypoxic respiratory failure and provide new insights that will guide clinical use of this support strategy to bridge patients to lung transplant., Methods: Employing a patient-specific vascular geometry and a quantitative model of oxygen transport, computational simulations were performed to determine hemodynamics and oxygen delivery in the ascending and descending aorta, left and right coronary arteries, and great vessels during upper body VA ECMO support. Oxygen content in ECMO circuit blood flow was varied while considering different degrees of lung failure severity. Using lumped parameter models to dynamically apply perfusion boundary conditions, hemodynamic parameters and oxygen content were analyzed to assess the effect of ECMO supply titration., Results: The results emphasize the importance of anatomical distribution for tissue oxygen delivery in severe lung failure, with ECMO-derived flow primarily augmenting oxygen content in specific vascular beds. They also demonstrate that although cannulating the subclavian artery can enhance cerebral oxygen delivery, its ability to ensure sufficient oxygen delivery to the coronary circulation seems to be comparatively restricted., Conclusions: The oxygen delivery to a specific vascular area is primarily determined by the oxygen content in the source of perfusion. Caution is advised with upper body VA ECMO for patients with hypoxic respiratory failure and right ventricle dysfunction, due to potential coronary ischemia. Management of these patients is challenging due to disease progression and organ availability uncertainties., Competing Interests: Declaration of competing interest Hamed Moradi denies any competing interests. Raghu Seethala denies any competing interests. Elazer Edelman is the primary investigator of an educational grant to the Massachusetts Institute of Technology (MIT) from Abiomed, Inc. that investigates use of mechanical circulatory support devices. He has developed intellectual property that is licensed to Abiomed, Inc. through MIT. This work is in the related field of mechanical support but is not directly related to the submitted work. Farhad Nezami denies any competing interests. Steven Keller is a co-inventor of intellectual property with Dr. Edelman that is licensed to Abiomed, Inc. through MIT. This work is not directly related to the submitted work., (Copyright © 2024. Published by Elsevier Ltd.)
- Published
- 2024
- Full Text
- View/download PDF